Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

GSK

GSK Plc ADR

Apr 24 • 04:00PM ET

40.86

Dollar change -0.38
Percentage change -0.92	%

Healthcare • Drug Manufacturers - General • United Kingdom • NYSE

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	13.66	EPS (ttm)	2.99	Insider Own	0.01%	Shs Outstand	2.03B	Perf Week	3.18%
Market Cap	82.91B	Forward P/E	9.32	EPS next Y	4.38	Insider Trans	0.00%	Shs Float	2.03B	Perf Month	-4.60%
Income	6.13B	PEG	2.85	EPS next Q	0.92	Inst Own	14.98%	Short Float	0.24%	Perf Quarter	4.69%
Sales	37.73B	P/S	2.20	EPS this Y	-1.96%	Inst Trans	0.60%	Short Ratio	1.36	Perf Half Y	14.13%
Book/sh	8.39	P/B	4.87	EPS next Y	13.20%	ROA	8.31%	Short Interest	4.83M	Perf Year	11.49%
Cash/sh	3.26	P/C	12.55	EPS next 5Y	4.80%	ROE	41.19%	52W Range	33.33 - 43.84	Perf YTD	10.25%
Dividend Est.	1.52 (3.73%)	P/FCF	13.31	EPS past 5Y	4.23%	ROI	16.84%	52W High	-6.80%	Beta	0.67
Dividend TTM	1.47 (3.59%)	Quick Ratio	0.62	Sales past 5Y	-1.06%	Gross Margin	70.52%	52W Low	22.59%	ATR (14)	0.59
Dividend Ex-Date	Feb 22, 2024	Current Ratio	0.88	EPS Y/Y TTM	-64.86%	Oper. Margin	22.97%	RSI (14)	47.97	Volatility	1.40% 1.25%
Employees	70212	Debt/Eq	1.35	Sales Y/Y TTM	-4.87%	Profit Margin	16.25%	Recom	2.24	Target Price	47.66
Option/Short	Yes / Yes	LT Debt/Eq	1.14	EPS Q/Q	-75.40%	Payout	47.48%	Rel Volume	0.47	Prev Close	41.24
Sales Surprise	6.12%	EPS Surprise	0.08%	Sales Q/Q	15.46%	Earnings	May 01 BMO	Avg Volume	3.56M	Price	40.86
SMA20	-0.49%	SMA50	-2.33%	SMA200	7.98%	Trades		Volume	1,674,609	Change	-0.92%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-04-24	Upgrade	Guggenheim	Neutral → Buy
Feb-13-24	Upgrade	Citigroup	Neutral → Buy
Jan-23-24	Initiated	Morgan Stanley	Equal-Weight	$44
Jan-16-24	Resumed	UBS	Buy
Jan-03-24	Upgrade	Jefferies	Hold → Buy	$48
Jul-14-23	Initiated	HSBC Securities	Reduce
Mar-17-23	Upgrade	Deutsche Bank	Hold → Buy
Feb-27-23	Resumed	Goldman	Buy
Jan-03-23	Downgrade	JP Morgan	Neutral → Underweight
Dec-05-22	Downgrade	BofA Securities	Neutral → Underperform
Nov-11-22	Downgrade	UBS	Neutral → Sell
Sep-15-22	Upgrade	Credit Suisse	Underperform → Neutral
Sep-08-22	Downgrade	Jefferies	Buy → Hold	$50.50 → $34
Aug-05-22	Resumed	Morgan Stanley	Equal-Weight
Jul-21-22	Resumed	Citigroup	Neutral
Feb-11-22	Downgrade	DZ Bank	Buy → Hold
Nov-05-21	Upgrade	Barclays	Underweight → Equal Weight
Jun-24-21	Upgrade	Deutsche Bank	Sell → Hold
Mar-23-21	Downgrade	SVB Leerink	Outperform → Mkt Perform
Feb-04-21	Downgrade	Deutsche Bank	Hold → Sell

Show Previous Ratings

Today 10:01AM	GSK (GSK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Apr-17-24 09:40AM	Why GSK (GSK) is a Top Value Stock for the Long-Term (Zacks)
Apr-16-24 11:52AM	14 Cheap Penny Stocks to Buy According to Analysts (Insider Monkey)
Apr-11-24 05:50PM	GSK (GSK) Rises But Trails Market: What Investors Should Know (Zacks)
Apr-06-24 08:47PM	10 Best Weight Loss Drug Stocks to Buy Now (Insider Monkey)
06:00PM	Loading…
Apr-05-24 06:00PM	GSK (GSK) Rises Yet Lags Behind Market: Some Facts Worth Knowing (Zacks)
05:52PM	Health Care Roundup: Market Talk (The Wall Street Journal)
Mar-28-24 09:00AM	GSK PLC Sponsored ADR (GSK) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Mar-27-24 09:17PM	UPDATE 1-U.S. FDA approves Akebia's anemia drug (Reuters)
Mar-26-24 06:15PM	GSK (GSK) Stock Moves -0.09%: What You Should Know (Zacks)
09:53AM	WuXi Biologics Reports Solid 2023 Annual Results (PR Newswire)
05:10AM	32 Countries with the Highest Rates of Diabetes (Insider Monkey)
Mar-24-24 03:54PM	12 Best Biotech Penny Stocks to Invest In (Insider Monkey)
03:23AM	Billionaires Are Snapping Up Beaten-Down 23andMe Stock. Should You Follow Their Lead? (Motley Fool)
Mar-22-24 10:54AM	After GSK acquisition, Bellus CEO seeks work opportunities for displaced staff (FierceBiotech.com)
06:00PM	Loading…
Mar-19-24 06:00PM	GSK (GSK) Increases Yet Falls Behind Market: What Investors Need to Know (Zacks)
12:19PM	Pfizer to Raise Around $3.5 Billion From Haleon Shares Sale (The Wall Street Journal)
10:31AM	Pfizer Sells $3.5 Billion of Shares in Haleon (Bloomberg)
Mar-18-24 03:06PM	Now That Two Inhaler Makers Are Capping Patient Costs, Will More Follow? (The Wall Street Journal)
09:20AM	ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2023 Earnings Call Transcript (Insider Monkey)
09:09AM	AlTi Global, Inc. (NASDAQ:ALTI) Q4 2023 Earnings Call Transcript (Insider Monkey)
05:17AM	Pfizer Plans to Sell About £2 Billion of Shares in Haleon (Bloomberg)
Mar-16-24 08:00AM	Positive RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancer (Business Wire)
Mar-15-24 12:51PM	Spero Therapeutics, Inc. (NASDAQ:SPRO) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-14-24 09:38AM	12 Most Profitable Biotech Stocks To Invest In (Insider Monkey)
09:00AM	GSK PLC Sponsored ADR (GSK) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Mar-13-24 09:40AM	Has GSK PLC Sponsored ADR (GSK) Outpaced Other Medical Stocks This Year? (Zacks)
Mar-12-24 10:20AM	Global Contraceptive Drugs Market Size is Projected to Reach USD 28.96 billion by 2030, Growing at a CAGR of 7.3%: Straits Research (GlobeNewswire)
Mar-09-24 10:06AM	10 New Alternatives to Antibiotics: Alternative Therapeutic Strategies to Treat Antibiotic-Resistant Pathogens (Insider Monkey)
Mar-07-24 12:00PM	GSK Doubles COiMMUNITY Grant Funding, Launches Patient Resources, as Adult Vaccination Rates Begin to Show Promising Rise (Business Wire)
08:24AM	Loading…
08:24AM	Adaptimmune Therapeutics plc (NASDAQ:ADAP) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-06-24 08:03AM	UK NICE recommends GSK's Dostarlimab regimen for womb cancer (Pharmaceutical Business Review)
Mar-05-24 02:56AM	13 Best Pharma Dividend Stocks To Buy in 2024 (Insider Monkey)
Mar-01-24 11:30AM	Glaxo (GSK) Up 3.1% Since Last Earnings Report: Can It Continue? (Zacks)
09:00AM	Once a Hot Stock-Market Trend Has a Name, Its Best Days Are Likely Past (The Wall Street Journal)
Feb-29-24 04:37PM	Innoviva Inc (INVA) Reports Growth Amidst Challenges in Q4 and Full Year 2023 Financial Results (GuruFocus.com)
09:00AM	Investors Heavily Search GSK PLC Sponsored ADR (GSK): Here is What You Need to Know (Zacks)
02:52AM	Haleon Backs Views After Profit Rise on Robust Growth (The Wall Street Journal)
Feb-28-24 09:50AM	Here's Why GSK (GSK) is a Strong Momentum Stock (Zacks)
Feb-27-24 09:40AM	Here's Why GSK (GSK) is a Strong Value Stock (Zacks)
Feb-26-24 12:00PM	All You Need to Know About Glaxo (GSK) Rating Upgrade to Buy (Zacks)
09:40AM	Are Medical Stocks Lagging GSK PLC Sponsored ADR (GSK) This Year? (Zacks)
05:49AM	GSK, pushing back UTI filing by a year, shows antibiotic's gonorrhea potential in phase 3 (FierceBiotech.com)
Feb-23-24 05:12AM	GSK, Vir end flu drug alliance, removing key piece of $345M pact (FierceBiotech.com)
Feb-22-24 11:22AM	Moderna CEO: 2024 is year of growth, with 2023 transition in rearview (Yahoo Finance)
11:00AM	Moderna Is Pivoting From Covidthe Results Are on Their Way (The Wall Street Journal)
06:10AM	Move Over Magnificent 7, Say Hello to the GRANOLAS (InvestorPlace)
Feb-21-24 05:02AM	GSK PLC's Dividend Analysis (GuruFocus.com)
Feb-14-24 09:17AM	GSK still has a crush on oligonucleotides, sealing the deal with Elsie (FierceBiotech.com)
Feb-12-24 09:50AM	Why GSK (GSK) is a Top Momentum Stock for the Long-Term (Zacks)
Feb-10-24 08:30AM	30 Most Valuable Drug Companies in 2024 (Insider Monkey)
Feb-09-24 02:35PM	Moderna's stock slumps after RSV shot efficacy wanes faster than GSK's Arexvy (FierceBiotech.com)
Feb-08-24 07:00AM	Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer's Disease (GlobeNewswire)
Feb-07-24 04:01PM	23andMe Reports Third Quarter Fiscal 2024 Financial Results (GlobeNewswire)
07:00AM	FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN) (GlobeNewswire)
Feb-06-24 07:00AM	GSKs RSV Vaccine, AREXVY, Accepted Under Priority Review in US for the Prevention of RSV Disease in Adults Aged 50-59 at Increased Risk (Business Wire)
06:15AM	The 7 Best Healthcare Stocks to Invest In for Big Gains in 2024 (InvestorPlace)
Feb-05-24 09:45PM	UPDATE 1-US bill poses risk to Wuxi AppTec and its Western drugmaker partners (Reuters)
08:45PM	Lightning Round: I'm a believer in GSK, it could go higher, says Jim Cramer (CNBC TV)
06:02AM	US bill poses risk to Wuxi AppTec and its Western drugmaker partners (Reuters)
Feb-02-24 04:30PM	23andMe is low on cash and its stock is worth pennies. The CEO wants another chance (CNN Business)
Feb-01-24 05:14PM	Health Care Roundup: Market Talk (The Wall Street Journal)
11:46AM	GSK plc (NYSE:GSK) Q4 2023 Earnings Call Transcript (Insider Monkey)
07:46AM	Drugmaker Abbott India's Q3 profit rises on strong demand (Reuters)
Jan-31-24 05:05PM	Health Care Roundup: Market Talk (The Wall Street Journal)
04:59PM	Tech, Media & Telecom Roundup: Market Talk (The Wall Street Journal)
02:50PM	Analyst Report: GSK plc (Morningstar Research)
12:50PM	Novo Nordisk Tops $500 Billion Valuation; Ozempic, Wegovy Fuel Earnings (The Wall Street Journal)
11:00AM	Novo Nordisk Earnings Top Forecasts, Fueled by Ozempic, Wegovy Sales (The Wall Street Journal)
10:50AM	GSK Upgrades Long-Term Outlook After Q4 Performance, Shingrix Vaccine And Newly Launched RSV Vaccine Shine (Benzinga)
07:31AM	GSK tips 12 blockbuster launches to soften HIV patent loss, power sales toward $50B (FierceBiotech.com)
07:05AM	GSK (GSK) Misses Q4 Earnings Estimates (Zacks)
02:54AM	GSK Bets on Further Growth After Shingles and RSV Vaccines Boost Sales (The Wall Street Journal)
02:27AM	GSK Sales Rose on Shingles Vaccine Growth, RSV Drug Launch (The Wall Street Journal)
Jan-29-24 02:03PM	After GSK and Novartis handoffs, Laekna's drug fails ovarian cancer trial (FierceBiotech.com)
01:39AM	Novo Nordisk Puts Pharma Peers in the Shade as Key Earnings Reports Awaited (Bloomberg)
Jan-25-24 01:06PM	The Cutting Edge: 3 Stocks to Buy for the Next Generation of Biotech Breakthroughs (InvestorPlace)
09:40AM	Why GSK (GSK) is a Top Value Stock for the Long-Term (Zacks)
Jan-24-24 10:08AM	Private equity firm Yellow Wood close to deal to acquire ChapStick-sources (Reuters)
10:00AM	GSK (GSK) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
08:00AM	Elegen and GSK Sign Collaboration and Licensing Agreement to Further Develop Elegens Cell-Free DNA Production Technology (Business Wire)
05:36AM	The Cutting Edge: 3 Stocks to Buy for the Next Generation of Biotech Breakthroughs (InvestorPlace)
Jan-23-24 08:00AM	Warren Buffett used to think that 'predicting' the stock market was the most important thing in investing until 1 book changed his life forever. Here's the real key to long-term gains (Moneywise)
Jan-21-24 08:27AM	5 Most Profitable New Stocks Today (Insider Monkey)
Jan-18-24 02:41PM	Drugmakers Raise Prices of Ozempic, Mounjaro and Hundreds of Other Drugs (The Wall Street Journal)
Jan-09-24 01:49PM	GSK Boosts Respiratory Portfolio with $1.4 Billion Aiolos Bio Acquisition (Investopedia)
01:14PM	Stocks to Watch Tuesday: Boeing, Match, HPE, JetBlue (The Wall Street Journal)
12:32PM	Health Care Roundup: Market Talk (The Wall Street Journal)
05:52AM	GSK Enters Agreement to Acquire Aiolos Bio (Business Wire)
05:11AM	GSK, moving fast to buy Aiolos, pays $1B to challenge Amgen, AstraZeneca for asthma market (FierceBiotech.com)
03:07AM	GSK Expands Respiratory Pipeline With Aiolos Bio Buy (The Wall Street Journal)
02:49AM	JPM24, Day 2: GSK gets in on the M&A action (FierceBiotech.com)
02:35AM	GSK Buys Aiolos Bio for Up to $1.4 Bln (The Wall Street Journal)
Jan-08-24 08:18PM	Analyst Report: GSK plc (Morningstar Research)
06:58AM	Curevo's shingles vaccine equals GSK's Shingrix in phase 2 head-to-head (FierceBiotech.com)
Jan-05-24 12:10PM	Why Glaxo (GSK) is Poised to Beat Earnings Estimates Again (Zacks)
06:12AM	Sleeper Hits: 3 Unexpected Stocks Poised for a Breakout in 2024 (InvestorPlace)
Jan-03-24 04:24AM	UPDATE 2-Miners, personal goods stocks drag FTSE 100 to two-week low (Reuters)
Dec-29-23 11:57AM	How Lowering The Price of a Common Asthma Drug Made It Harder to Get (The Wall Street Journal)
Dec-24-23 05:34PM	15 Undervalued Defensive Stocks For 2024 (Insider Monkey)

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
GSK plc	10% Owner	Dec 07 '23	Buy	5.00	3,300,000	16,500,000	13,983,761	Jan 30 04:39 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GSK

GSK Plc ADR

Upgrade your FINVIZ experience